NULL
OncoSec (ONCS) Announces Positive Updated Long-Term Follow-Up Data from Phase 2 Trial of ImmunoPulse
OncoSec Medical Incorporated (NASDAQ:ONCS) today announced positive updated long-term follow-up data from its Phase 2 OMS I-102
- 1 min Read
- 11.8.2017
A weekly five-point roundup of critical events in the energy transition and the implications of climate change for business and finance.
A weekly five-point roundup of critical events in fintech, the future of finance and the next wave of banking industry transformation.
A weekly five-point roundup of critical events in fintech, the future of finance and the next wave of banking industry transformation.
